Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 5,837	$ 4,416	$ 10,177	$ 9,094
General and administrative	3,745	3,054	7,379	5,957
Loss from operations	(9,582)	(7,470)	(17,556)	(15,051)
Other income (expense), net:
Interest expense	(372)	(355)	(740)	(699)
Interest income and other income (expense), net	384	244	822	533
Total other income (expense), net	12	(111)	82	(166)
Provision for income taxes	0	0	0	0
Net loss	$ (9,570)	$ (7,581)	$ (17,474)	$ (15,217)
Net loss per share of common stock, RSUs and pre-funded warrants, basic	$ (0.42)	$ (0.54)	$ (0.78)	$ (1.09)
Net loss per share of common stock, RSUs and pre-funded warrants, diluted	$ (0.42)	$ (0.54)	$ (0.78)	$ (1.09)
Weighted-average shares of common stock, RSUs and pre-funded warrants outstanding, basic	22,546,370	14,102,211	22,390,298	13,933,629
Weighted-average shares of common stock, RSUs and pre-funded warrants outstanding, diluted	22,546,370	14,102,211	22,390,298	13,933,629